Healthcare Utilisation and Costs in Adults with Type 2 Diabetes Treated with First- or Second-Generation Basal Insulins in England
(2025)
Journal Article
Holden, N., Diribe, O., Palmer, K., Puttanna, A., Mahieu, A., Nicholls, C., Li Marston, X., Denholm, N., Saberi Hosnijeh, F., & Idris, I. (in press). Healthcare Utilisation and Costs in Adults with Type 2 Diabetes Treated with First- or Second-Generation Basal Insulins in England. BMJ Open Diabetes Research and Care,
Introduction: The prevalence of people with type 2 diabetes (T2D) on basal insulin (BI) is rising to improve glucose control and minimize minimise complications. However, limited evidence exists regarding the economic impact of second-generation BI a... Read More about Healthcare Utilisation and Costs in Adults with Type 2 Diabetes Treated with First- or Second-Generation Basal Insulins in England.